PL2320908T3 - Proleki dolutegrawiru - Google Patents

Proleki dolutegrawiru

Info

Publication number
PL2320908T3
PL2320908T3 PL09800989T PL09800989T PL2320908T3 PL 2320908 T3 PL2320908 T3 PL 2320908T3 PL 09800989 T PL09800989 T PL 09800989T PL 09800989 T PL09800989 T PL 09800989T PL 2320908 T3 PL2320908 T3 PL 2320908T3
Authority
PL
Poland
Prior art keywords
dolutegravir
prodrugs
dolutegravir prodrugs
Prior art date
Application number
PL09800989T
Other languages
English (en)
Inventor
Brian Alvin Johns
Jason Gordon Weatherhead
Yasunori Aoyama
Toshikazu Hakogi
Original Assignee
Viiv Healthcare Co
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viiv Healthcare Co, Shionogi & Co filed Critical Viiv Healthcare Co
Publication of PL2320908T3 publication Critical patent/PL2320908T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL09800989T 2008-07-25 2009-07-23 Proleki dolutegrawiru PL2320908T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8361208P 2008-07-25 2008-07-25
PCT/US2009/051497 WO2010011812A1 (en) 2008-07-25 2009-07-23 Chemical compounds
EP09800989.7A EP2320908B9 (en) 2008-07-25 2009-07-23 Dolutegravir Prodrugs

Publications (1)

Publication Number Publication Date
PL2320908T3 true PL2320908T3 (pl) 2014-06-30

Family

ID=41570593

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09800989T PL2320908T3 (pl) 2008-07-25 2009-07-23 Proleki dolutegrawiru

Country Status (12)

Country Link
US (1) US8217034B2 (pl)
EP (1) EP2320908B9 (pl)
CY (1) CY1114981T1 (pl)
DK (1) DK2320908T3 (pl)
ES (1) ES2448766T3 (pl)
HR (1) HRP20140223T2 (pl)
HU (1) HUE020489T4 (pl)
PL (1) PL2320908T3 (pl)
PT (1) PT2320908E (pl)
SI (1) SI2320908T1 (pl)
SM (1) SMT201400030B (pl)
WO (1) WO2010011812A1 (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2660239B1 (en) 2008-07-25 2016-11-23 VIIV Healthcare Company Chemical compounds as synthetic intermediates
ES2645773T3 (es) 2008-12-11 2017-12-07 Shionogi & Co., Ltd. Procedimientos e intermediarios de éter de maltol
AU2014277831C1 (en) * 2008-12-11 2022-10-06 Shionogi & Co. Ltd. Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
SG171308A1 (en) * 2008-12-11 2011-07-28 Shionogi & Co Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
EP3617194B1 (en) * 2008-12-11 2023-11-08 VIIV Healthcare Company Processes and intermediates for carbamoylpyridone hiv integrase inhibitors
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
EP3351249A1 (en) 2010-01-27 2018-07-25 VIIV Healthcare Company Antiviral therapy
TWI582097B (zh) 2010-03-23 2017-05-11 Viiv醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法
WO2011129095A1 (ja) * 2010-04-12 2011-10-20 塩野義製薬株式会社 インテグラーゼ阻害活性を有するピリドン誘導体
SMT202100268T1 (it) 2010-08-05 2021-07-12 Shionogi & Co Metodo per produrre composti aventi attività di inibizione di integrasi di hiv.
LT2620436T (lt) * 2010-09-24 2018-08-10 Shionogi & Co., Ltd. Pakeistojo policiklinio karbamoilpiridono darinio provaistas
PL2742051T3 (pl) * 2011-09-14 2017-06-30 Mapi Pharma Limited Amorficzna postać soli sodowej dolutegrawiru
EA030003B1 (ru) 2012-12-21 2018-06-29 Джилид Сайэнс, Инк. Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции
WO2014128545A2 (en) 2013-02-19 2014-08-28 Aurobindo Pharma Limited An improved process for the preparation of dolutegravir
US9951079B2 (en) 2013-06-13 2018-04-24 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
EP3016935B1 (en) 2013-07-04 2018-09-05 Hetero Research Foundation Process for the preparation of intermediate of dolutegravir
DK3019503T3 (da) 2013-07-12 2017-11-20 Gilead Sciences Inc Polycykliske-carbamoylpyridon-forbindelser og anvendelse deraf til behandling af hiv-infektioner
NO2865735T3 (pl) 2013-07-12 2018-07-21
EP3022209B1 (en) * 2013-07-17 2018-03-07 ratiopharm GmbH Dolutegravir potassium salt
US9856271B2 (en) * 2014-01-21 2018-01-02 Laurus Labs Limited Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
WO2015138933A1 (en) 2014-03-13 2015-09-17 Assia Chemical Industries Ltd. Solid state forms of dolutegravir sodium
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (pl) 2014-06-20 2018-06-23
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
CA2980362C (en) 2015-04-02 2020-02-25 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
JP7160466B2 (ja) * 2016-06-23 2022-10-25 ヴィーブ ヘルスケア カンパニー 治療薬の送達のための組成物及び方法
CN106360086B (zh) * 2016-09-23 2020-06-30 皖西学院 一种皖西白鹅种鹅专用饲料组合物、制备方法及使用方法
CN108250215B (zh) * 2016-12-28 2022-04-19 华创合成制药股份有限公司 一种新型抗hiv药物及其制备方法和用途
WO2018140368A1 (en) 2017-01-26 2018-08-02 Merck Sharp & Dohme Corp. Substituted quinolizine derivatives useful as hiv integrase inhibitors
RU2755710C2 (ru) 2017-06-30 2021-09-20 Вайв Хелткер Компани Комбинация, ее применение и способы лечения с использованием указанной комбинации
US11286262B2 (en) 2017-10-06 2022-03-29 Shionogi & Co., Ltd. Stereoselective process for preparing substituted polycyclic pyridone derivatives
KR20240151256A (ko) 2019-03-22 2024-10-17 길리애드 사이언시즈, 인코포레이티드 가교된 트리시클릭 카르바모일피리돈 화합물 및 그의 제약 용도
EP4110783A1 (en) 2020-02-24 2023-01-04 Gilead Sciences, Inc. Tetracyclic compounds for treating hiv infection
CN116390924B (zh) 2020-09-30 2025-11-07 吉利德科学公司 桥连三环氨基甲酰基吡啶酮化合物及其用途
WO2022107755A1 (ja) 2020-11-17 2022-05-27 塩野義製薬株式会社 新規アクリジニウム塩およびその製造方法
CR20260070A (es) 2021-01-19 2026-04-24 Gilead Sciences Inc COMPUESTOS DE PIRIDOTRIAZINA SUSTITUIDOS Y USOS DE ESTOS (Divisional 2023-0315)
US11958864B2 (en) * 2021-02-16 2024-04-16 Merck Sharp & Dohme Llc Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
WO2023183472A1 (en) * 2022-03-23 2023-09-28 Board Of Regents Of The University Of Nebraska Antiviral prodrugs and use thereof
CN118974266A (zh) 2022-04-04 2024-11-15 约翰内斯堡威特沃特斯兰德大学 制备手性胺中间体的对映选择性方法
TWI856796B (zh) 2022-04-06 2024-09-21 美商基利科學股份有限公司 橋聯三環胺甲醯基吡啶酮化合物及其用途
CN120936599A (zh) * 2023-01-18 2025-11-11 歌礼生物科技(杭州)有限公司 整合酶抑制剂及其应用
IL327206A (en) 2023-10-11 2026-05-01 Gilead Sciences Inc Bridged tricyclic carbamoylpyridone compounds and their uses
AU2024360779A1 (en) 2023-10-11 2026-04-16 Gilead Sciences, Inc. Bridged tricyclic carbamoylpyridone compounds and uses thereof
WO2026076265A1 (en) 2024-10-03 2026-04-09 Gilead Sciences, Inc. Combination therapy comprising bridged tricyclic carbamoylpyridone compounds and p-glycoprotein inhibitors
WO2026128357A1 (en) 2024-12-09 2026-06-18 Gilead Sciences, Inc. Methods and compositions for treating viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1742642T1 (sl) 2004-04-14 2009-04-30 Gilead Sciences Inc Fosfonatni analogi inhibitorskih spojin HIV integraze
WO2006088173A1 (ja) 2005-02-21 2006-08-24 Shionogi & Co., Ltd. Hivインテグラーゼ阻害活性を有する2環性カルバモイルピリドン誘導体
DK3187225T3 (da) * 2005-04-28 2022-02-28 Viiv Healthcare Co Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet
US20070072831A1 (en) 2005-05-16 2007-03-29 Gilead Sciences, Inc. Integrase inhibitor compounds

Also Published As

Publication number Publication date
EP2320908A4 (en) 2011-10-26
US8217034B2 (en) 2012-07-10
CY1114981T1 (el) 2016-12-14
EP2320908B1 (en) 2013-12-25
SI2320908T1 (sl) 2014-05-30
SMT201400030B (it) 2014-05-07
EP2320908A1 (en) 2011-05-18
ES2448766T9 (es) 2014-09-05
ES2448766T3 (es) 2014-03-17
WO2010011812A1 (en) 2010-01-28
DK2320908T3 (en) 2014-03-10
PT2320908E (pt) 2014-03-06
HUE020489T4 (hu) 2016-01-28
HRP20140223T1 (en) 2014-04-11
US20110190236A1 (en) 2011-08-04
EP2320908B9 (en) 2014-06-18
HRP20140223T2 (hr) 2014-08-01

Similar Documents

Publication Publication Date Title
HRP20140223T1 (en) Dolutegravir prodrugs
EP2118052A4 (en) NEW PRODRUGS
GB2463990B (en) RainDirector
TWI368572B (en) Printing-table arrangement
GB0817732D0 (en) Teletruck
GB0800389D0 (en) Gileo hang-it
GB0815714D0 (en) Platyfin
GB2463042B (en) Stabalizer arrangement
GB0915525D0 (en) Kat2
GB0803221D0 (en) Wrist-pull
GB0803099D0 (en) Pro-bolt
GB0905127D0 (en) Novel prodrugs
GB0814188D0 (en) Magnamo
GB0808025D0 (en) T-clip
GB0819342D0 (en) Traffiglove
GB0820656D0 (en) Drydam
IL192410A0 (en) Îéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîé
GB0817372D0 (en) Gripezee
GB0820313D0 (en) Pixelroller
GB0823023D0 (en) Aerojection
IL190149A0 (en) Îéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîéîé
GB0817916D0 (en) Measure-aides
GB0804357D0 (en) Ntsc-pal-secam
GB0803244D0 (en) Statmove
GB0802462D0 (en) Aerpurifiers